A 2 Amino acid shift in position leads to a substantial difference in the pattern of processing of 2 HIV-1 epitopes

Journal of Acquired Immune Deficiency Syndromes

Volumn 59, Issue 4, 2012, Pages 335-339

  Culshaw, Abigail ^a   Dong, Tao ^a   Rowland Jones, Sarah Louise ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antigen processing; CD8+ T cells; HIV 1

Indexed keywords

EPITOPE; HLA B40 ANTIGEN; NEF PROTEIN;

ANTIGEN PRESENTATION; ARTICLE; CLADISTICS; CYTOTOXIC T LYMPHOCYTE; DEGRANULATION; HLA MATCHING; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS GENE;

AIDS VACCINES; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGEN PRESENTATION; CELLS, CULTURED; EPITOPES; HIV ANTIGENS; HIV-1; HLA-B40 ANTIGEN; HLA-B8 ANTIGEN; HUMANS; MOLECULAR SEQUENCE DATA; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84859742576     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318248780c     Document Type: Article

References (31)

1. Alter G, Moody MA. The humoral response to HIV-1: new insights, renewed focus. J Infect Dis. 2010;202(suppl 2):S315-S322.
2. Gray ES, Madiga MC, Moore PL, et al. Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region. J Virol. 2009;83:11265-11274.
3. Pereyra F, Jia X, McLaren PJ, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010; 330:1551-1557.
4. Fellay J, Shianna KV, Ge D, et al. A whole-genome association study of major determinants for host control of HIV-1. Science. 2007;317:944-947. (Pubitemid 47301321)
5. Moore CB, John M, James IR, et al. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science. 2002; 296:1439-1443. (Pubitemid 34553083)
6. Gao X, Nelson GW, Karacki P, et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med. 2001;344:1668-1675. (Pubitemid 32479964)
7. Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 1999; 283:857-860.
8. Jin X, Bauer DE, Tuttleton SE, et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med. 1999;189:991-998. (Pubitemid 29149355)
9. Carrington M, Nelson GW, Martin MP, et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science. 1999;283: 1748-1752.
10. Price DA, Goulder PJ, Klenerman P, et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A. 1997;94:1890-1895. (Pubitemid 27113932)
11. Haynes BF, Pantaleo G, Fauci AS. Toward an understanding of the correlates of protective immunity to HIV infection. Science. 1996;271: 324-328.
12. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994;68:4650-4655. (Pubitemid 24183063)
13. Borrow P, Lewicki H, Hahn BH, et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primaryhuman immunodeficiency virus type 1 infection. J Virol. 1994;68: 6103-6110. (Pubitemid 24258634)
14. Phillips RE, Rowland-Jones S, Nixon DF, et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature. 1991;354:453-459. (Pubitemid 21896855)
15. McMichael AJ. HIV vaccines. Annu Rev Immunol. 2006;24:227-255.
16. Roberts JD, Bebenek K, Kunkel TA. The accuracy of reverse transcriptasefrom HIV-1. Science. 1988;242:1171-1173.
17. Boyer JC, Bebenek K, Kunkel TA. Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates. Proc Natl Acad Sci U S A. 1992;89:6919-6923.
18. Korber B, Gaschen B, Yusim K, et al. Evolutionary and immunological implications of contemporary HIV-1 variation. Br Med Bull. 2001;58:19-42. (Pubitemid 33070762)
19. Letourneau S, Im EJ, Mashishi T, et al. Design and pre-clinical evaluation of a universal HIV-1 vaccine. PLoS One. 2007;2:e984.
20. Frahm N, Nickle DC, Linde CH, et al. Increased detection of HIVspecific T cell responses by combination of central sequences with comparable immunogenicity. AIDS. 2008;22:447-456. (Pubitemid 351317286)
21. Santra S, Korber BT, Muldoon M, et al. A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys. Proc Natl Acad Sci U S A. 2008;105:10489-10494.
22. Draenert R, Le Gall S, Pfafferott KJ, et al. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J Exp Med. 2004;199:905-915. (Pubitemid 38481082)
23. Milicic A, Price DA, Zimbwa P, et al. CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef. J Immunol. 2005;175:4618-4626. (Pubitemid 41362001)
24. Zimbwa P, Milicic A, Frater J, et al. Precise identification of a human immunodeficiency virus type 1 antigen processing mutant. J Virol. 2007; 81:2031-2038. (Pubitemid 46214474)
25. Ranasinghe SR, Kramer HB, Wright C, et al. The antiviral efficacy of HIV-specific CD8 T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate. PLoS Pathog. 2011;7:e1001341.
26. Dong T, Stewart-Jones G, Chen N, et al. HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J Exp Med. 2004;200:1547-1557. (Pubitemid 40094179)
27. Cascio P, Hilton C, Kisselev AF, et al. 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J. 2001;20:2357-2366. (Pubitemid 32452853)
28. Saric T, Chang SC, Hattori A, et al. An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat Immunol. 2002;3:1169-1176. (Pubitemid 35476828)
29. McCluskey J, Rossjohn J, Purcell AW. TAP genes and immunity. Curr Opin Immunol. 2004;16:651-659. (Pubitemid 39165894)
30. Seifert U, Liermann H, Racanelli V, et al. Hepatitis C virus mutation affects proteasomal epitope processing. J Clin Invest. 2004;114:250-259. (Pubitemid 39071630)
31. Theobald M, Ruppert T, Kuckelkorn U, et al. The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope. J Exp Med. 1998;188:1017-1028. (Pubitemid 28443325)